Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasmine Zain

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
JAAD Case Reports|December 9, 2020
Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphomaBalaji Jothishankar, Maria L Espinosa, Jasmine Zain, et al.
Annals of Surgical Oncology|May 2, 2009
Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopeniaAndrew A Gumbs, Jasmine Zain, Ellen Neylon, et al.
American Journal of Surgery|October 29, 2021
Cholecystectomy in patients with hematologic malignanciesCamille L Stewart, Thuy B Tran, Andrew Nguyen, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 22, 2010
Acute orbitocranial inflammation following radioimmunotherapy for non-Hodgkin lymphomaJohn C Hwang, Tarek El-Sawy, Christopher I Zoumalan, et al.
Best Practice & Research. Clinical Haematology|October 6, 2019
Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndromeXochiquetzal U Martinez, Cosimo Di Raimondo, Farah R Abdulla, et al.
British Journal of Haematology|February 16, 2026
Pembrolizumab and pralatrexate for relapsed or refractory peripheral T-cell lymphomasChristina Poh, Jasmine Zain, James Godfrey, et al.
JAMA Dermatology|October 22, 2025
T-Cell Receptor Clonotypes and Aggressive Subtypes in Cutaneous T-Cell LymphomaLiliana L Crisan, Shanpeng J Li, Michelle Afkhami, et al.
Journal of Clinical Medicine|June 28, 2023
Integrative Oncology and the Clinical Care Network: Challenges and OpportunitiesGeorge Semeniuk, Bahareh Bahadini, Eugene Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoidesArturo Molina, Jasmine Zain, Daniel A Arber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapiesKieron Dunleavy, Richard L Piekarz, Jasmine Zain, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
JAAD Case Reports|December 9, 2020
Complete response to romidepsin as monotherapy in treatment-resistant subcutaneous panniculitis-like T-cell lymphomaBalaji Jothishankar, Maria L Espinosa, Jasmine Zain, et al.
Annals of Surgical Oncology|May 2, 2009
Importance of early splenectomy in patients with hepatosplenic T-cell lymphoma and severe thrombocytopeniaAndrew A Gumbs, Jasmine Zain, Ellen Neylon, et al.
American Journal of Surgery|October 29, 2021
Cholecystectomy in patients with hematologic malignanciesCamille L Stewart, Thuy B Tran, Andrew Nguyen, et al.
Ophthalmic Plastic and Reconstructive Surgery|May 22, 2010
Acute orbitocranial inflammation following radioimmunotherapy for non-Hodgkin lymphomaJohn C Hwang, Tarek El-Sawy, Christopher I Zoumalan, et al.
Best Practice & Research. Clinical Haematology|October 6, 2019
Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and Sézary syndromeXochiquetzal U Martinez, Cosimo Di Raimondo, Farah R Abdulla, et al.
British Journal of Haematology|February 16, 2026
Pembrolizumab and pralatrexate for relapsed or refractory peripheral T-cell lymphomasChristina Poh, Jasmine Zain, James Godfrey, et al.
JAMA Dermatology|October 22, 2025
T-Cell Receptor Clonotypes and Aggressive Subtypes in Cutaneous T-Cell LymphomaLiliana L Crisan, Shanpeng J Li, Michelle Afkhami, et al.
Journal of Clinical Medicine|June 28, 2023
Integrative Oncology and the Clinical Care Network: Challenges and OpportunitiesGeorge Semeniuk, Bahareh Bahadini, Eugene Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2005
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoidesArturo Molina, Jasmine Zain, Daniel A Arber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2010
New strategies in peripheral T-cell lymphoma: understanding tumor biology and developing novel therapiesKieron Dunleavy, Richard L Piekarz, Jasmine Zain, et al.
Pageof 12